342 related articles for article (PubMed ID: 28677532)
1. Establishment of an induced pluripotent stem cell (iPSC) line from a 9-year old male with autism spectrum disorder (ASD).
Varga E; Nemes C; Bock I; Táncos Z; Berzsenyi S; Lévay G; Román V; Kobolák J; Dinnyés A
Stem Cell Res; 2017 May; 21():19-22. PubMed ID: 28677532
[TBL] [Abstract][Full Text] [Related]
2. Establishment of induced pluripotent stem cell (iPSC) line from a 57-year old patient with sporadic Alzheimer's disease.
Ochalek A; Nemes C; Varga E; Táncos Z; Kobolák J; Dinnyés A
Stem Cell Res; 2016 Jul; 17(1):72-74. PubMed ID: 27558605
[TBL] [Abstract][Full Text] [Related]
3. Establishment of induced pluripotent stem cell (iPSC) line from an 84-year old patient with late onset Alzheimer's disease (LOAD).
Táncos Z; Varga E; Kovács E; Dinnyés A; Kobolák J
Stem Cell Res; 2016 Jul; 17(1):75-77. PubMed ID: 27558606
[TBL] [Abstract][Full Text] [Related]
4. Establishment of induced pluripotent stem cell (iPSC) line from a 75-year old patient with late onset Alzheimer's disease (LOAD).
Táncos Z; Varga E; Kovács E; Dinnyés A; Kobolák J
Stem Cell Res; 2016 Jul; 17(1):81-83. PubMed ID: 27558608
[TBL] [Abstract][Full Text] [Related]
5. Establishment of induced pluripotent stem cell (iPSC) line from a 63-year old patient with late onset Alzheimer's disease (LOAD).
Chandrasekaran A; Varga E; Nemes C; Táncos Z; Kobolák J; Dinnyés A
Stem Cell Res; 2016 Jul; 17(1):78-80. PubMed ID: 27558607
[TBL] [Abstract][Full Text] [Related]
6. Establishment of EHMT1 mutant induced pluripotent stem cell (iPSC) line from a 11-year-old Kleefstra syndrome (KS) patient with autism and normal intellectual performance.
Varga E; Nemes C; Táncos Z; Bock I; Berzsenyi S; Lévay G; Román V; Kobolák J; Dinnyés A
Stem Cell Res; 2016 Nov; 17(3):531-533. PubMed ID: 27789404
[TBL] [Abstract][Full Text] [Related]
7. Generation of iPSC line (GIBHi001-A) from a patient with autism spectrum disorder.
Li S; Zhao H; Huang R; He L; Tian C; Huang H; Han X; Tang F; Lin Z; Deng S; Zhou J; Li Z
Stem Cell Res; 2019 Oct; 40():101571. PubMed ID: 31520889
[TBL] [Abstract][Full Text] [Related]
8. Generation of seven iPSC lines from peripheral blood mononuclear cells suitable to investigate Autism Spectrum Disorder.
Bozaoglu K; Gao Y; Stanley E; Fanjul-Fernández M; Brown NJ; Pope K; Green CC; Vlahos K; Sourris K; Bahlo M; Delatycki M; Scheffer I; Lockhart PJ
Stem Cell Res; 2019 Aug; 39():101516. PubMed ID: 31415975
[TBL] [Abstract][Full Text] [Related]
9. Generation of a human induced pluripotent stem cell (iPSC) line from a 64year old male patient with multiple schwannoma.
Zhang S; Lv Z; Hu Y; Liu L; Gong W; Li Q; Wu H
Stem Cell Res; 2017 Mar; 19():49-51. PubMed ID: 28413006
[TBL] [Abstract][Full Text] [Related]
10. Development of human induced pluripotent stem cell (iPSC) line from a 60year old female patient with multiple schwannoma.
Zhang S; Lv Z; Liu Y; Li Q; Gong W; Liu L; Wu H
Stem Cell Res; 2017 Mar; 19():31-33. PubMed ID: 28413001
[TBL] [Abstract][Full Text] [Related]
11. Derivation of human induced pluripotent stem cell (iPSC) line from a 79year old sporadic male Parkinson's disease patient.
Zhang S; Liu L; Hu Y; Lv Z; Li Q; Gong W; Sha H; Wu H
Stem Cell Res; 2017 Mar; 19():43-45. PubMed ID: 28413004
[TBL] [Abstract][Full Text] [Related]
12. Characterization of human induced pluripotent stem cell (iPSC) line from a 72year old male patient with later onset Alzheimer's disease.
Zhang S; Lv Z; Zhang S; Liu L; Li Q; Gong W; Sha H; Wu H
Stem Cell Res; 2017 Mar; 19():34-36. PubMed ID: 28413002
[TBL] [Abstract][Full Text] [Related]
13. Establishment of TUSMi004-A, an induced pluripotent stem cell (iPSC) line from a 32-year old Chinese Han patient with Obsessive-Compulsive Disorder (OCD).
Wang Y; Kang C; Yu H; Fen J; Ma X; Lei Y; Zhao J
Stem Cell Res; 2018 Oct; 32():83-86. PubMed ID: 30223146
[TBL] [Abstract][Full Text] [Related]
14. Derivation of human induced pluripotent stem cell (iPSC) line with LRRK2 gene R1398H variant in Parkinson's disease.
Ma D; Tio M; Ng SH; Li Zeng ; Lim CY; Zhao Y; Tan EK
Stem Cell Res; 2017 Jan; 18():48-50. PubMed ID: 28395803
[TBL] [Abstract][Full Text] [Related]
15. Generation of an induced pluripotent stem cell line from a patient with autism spectrum disorder and SCN2A haploinsufficiency.
Sampaio GLA; Martins GLS; Paredes BD; Nonaka CKV; da Silva KN; Rossi EA; Dos Santos RR; Soares MBP; Souza BSF
Stem Cell Res; 2019 Aug; 39():101488. PubMed ID: 31272037
[TBL] [Abstract][Full Text] [Related]
16. Reprogramming of a human induced pluripotent stem cell (iPSC) line from a Parkinson's disease patient with a R1628P variant in the LRRK2 gene.
Ma D; Zhou W; Ng EY; Zeng L; Zhao Y; Tan EK
Stem Cell Res; 2017 Jan; 18():45-47. PubMed ID: 28395802
[TBL] [Abstract][Full Text] [Related]
17. Development of a human induced pluripotent stem cell (iPSC) line from a Parkinson's disease patient carrying the N551K variant in LRRK2 gene.
Ma D; Ng EY; Zeng L; Lim CY; Zhao Y; Tan EK
Stem Cell Res; 2017 Jan; 18():51-53. PubMed ID: 28395804
[TBL] [Abstract][Full Text] [Related]
18. Generation of Mucopolysaccharidosis type II (MPS II) human induced pluripotent stem cell (iPSC) line from a 7-year-old male with pathogenic IDS mutation.
Varga E; Nemes C; Bock I; Varga N; Fehér A; Kobolák J; Dinnyés A
Stem Cell Res; 2016 Nov; 17(3):463-465. PubMed ID: 27789394
[TBL] [Abstract][Full Text] [Related]
19. Generation of a human induced pluripotent stem cell (iPSC) line carrying the Parkinson's disease linked LRRK2 variant S1647T.
Ma D; Ng SH; Zeng L; Zhao Y; Tan EK
Stem Cell Res; 2017 Jan; 18():54-56. PubMed ID: 28395805
[TBL] [Abstract][Full Text] [Related]
20. Generation and characterization of PBMCs-derived human induced pluripotent stem cell (iPSC) line SDQLCHi051-A from an autism spectrum disorder patient with compound CHD8 gene mutations.
Fan Y; Li Y; Yang X; Zhang H; Wang B; Guan J; Gao J; Ma X; Liu Y
Stem Cell Res; 2023 Jun; 69():103114. PubMed ID: 37229974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
